EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells (2020)
Source: Colloids and Surfaces B: Biointerfaces. Unidades: IQSC, FCFRP, FCF
Subjects: BIOQUÍMICA, NEOPLASIAS, PRÓSTATA, MEDICAMENTO
ABNT
ELOYA, Josimar O. et al. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. Colloids and Surfaces B: Biointerfaces, v. 194, p. 111185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2020.111185. Acesso em: 10 nov. 2024.APA
Eloya, J. O., Ruiz, A., Lima, F. T. de, Petrilli, R., Raspantini, G. L., Nogueira, K. A. B., et al. (2020). EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. Colloids and Surfaces B: Biointerfaces, 194, 111185. doi:10.1016/j.colsurfb.2020.111185NLM
Eloya JO, Ruiz A, Lima FT de, Petrilli R, Raspantini GL, Nogueira KAB, Santos E, Oliveira CS de, Borges JC, Marchetti JM, Al-Jamal WT, Chorilli M. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 194 111185.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111185Vancouver
Eloya JO, Ruiz A, Lima FT de, Petrilli R, Raspantini GL, Nogueira KAB, Santos E, Oliveira CS de, Borges JC, Marchetti JM, Al-Jamal WT, Chorilli M. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 194 111185.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111185